Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,340 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01107522 | Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas | unknown | Phase 1 | 100 | Tactical Therapeutics, Inc.INDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04951817 | 68Ga-PSMA PET/CT for Ra223 Assessment | unknown | N/A | 52 | Chang Gung Memorial HospitalOTHER | 1 | Aug 29, 2025 |
| clinicaltrials |
| NCT06018883 | Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer(PTCA199-3) | unknown | Phase 3 | 100 | Fudan UniversityOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06319755 | Characteristics of Intestinal Microbiome Following Pancreatic Surgery | unknown | — | 20 | Royal Prince Alfred Hospital, Sydney, AustraliaOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT06473766 | Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses(RFDATA) | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT05030597 | Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma(FAPI-OSCC) | unknown | — | 100 | Zhongnan HospitalOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06499831 | 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas(FETSMaRT) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT00567580 | Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer | unknown | Phase 3 | 1,792 | Radiation Therapy Oncology GroupNETWORK | 4 | May 9, 2025 | clinicaltrials |
| NCT02884102 | MMRF Molecular Profiling Protocol | unknown | — | 1,000 | Multiple Myeloma Research FoundationOTHER | 2 | May 6, 2025 | clinicaltrials |
| NCT06955156 | Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC | unknown | Phase 2 | 50 | QIAO LIOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT04767009 | SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors | unknown | Phase 2 | 59 | Fudan UniversityOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT05396950 | CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR(CPAP-RT) | unknown | N/A | 70 | Waikato HospitalOTHER | 0 | Apr 24, 2025 | clinicaltrials |
| NCT06873178 | The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer(PCLM:CSSG) | unknown | — | 50 | China-Japan Friendship HospitalOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06462716 | A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors | unknown | Phase 1 | 36 | Chengdu Baiyu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT05241093 | A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) | unknown | Phase 2 | 18 | Tarapeutics Science Inc.INDUSTRY | 1 | Apr 10, 2025 | clinicaltrials |
| NCT01885702 | Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI | unknown | Phase 1 / Phase 2 | 25 | Radboud University Medical CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06448936 | Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.(FACE-QOL) | unknown | — | 750 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT04097366 | Breast Screening - Risk Adaptive Imaging for Density(BRAID) | unknown | N/A | 9,000 | University of CambridgeOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT04757337 | Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients(GERICO14) | unknown | Phase 3 | 214 | UNICANCEROTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT05437380 | Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC | unknown | N/A | 70 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT04637763 | CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) | unknown | Phase 1 | 72 | Caribou Biosciences, Inc.INDUSTRY | 3 | Mar 24, 2025 | clinicaltrials |
| NCT05504265 | Perioperative Analgesia Modes in Minimally Invasive Esophagectomy | unknown | Phase 2 / Phase 3 | 102 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05628870 | A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer | unknown | Phase 1 | 102 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Mar 17, 2025 | clinicaltrials |
| NCT05992870 | Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction | unknown | N/A | 40 | Hubei Cancer HospitalOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06438705 | 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors | unknown | — | 20 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT02716012 | First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer(OUTREACH) | unknown | Phase 1 | 75 | Mina Alpha LimitedINDUSTRY | 3 | Mar 10, 2025 | clinicaltrials |
| NCT01903330 | ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme | unknown | Phase 2 | 84 | Epitopoietic Research CorporationINDUSTRY | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06497660 | Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia | unknown | Phase 4 | 496 | Fujian Medical University Union HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06857747 | Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. | unknown | N/A | 40 | QIAO LIOTHER | 0 | Mar 4, 2025 | clinicaltrials |
| NCT06532630 | Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies | unknown | Early Phase 1 | 9 | Shanghai First Song Biotechnology Co., LTDINDUSTRY | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06435117 | Cancer Prevention Among Individuals with Mental Ill-health: Patient Navigation for Primary Cancer Prevention(CO-CAPTAIN) | unknown | N/A | 1,240 | Medical University of ViennaOTHER | 4 | Feb 19, 2025 | clinicaltrials |
| NCT06832228 | Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL | unknown | N/A | 30 | Zhejiang Cancer HospitalOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06828341 | A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression | unknown | Early Phase 1 | 3 | JIANG LONGWEIOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05337189 | A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China | unknown | — | 482 | Creative Biosciences (Guangzhou) Co., Ltd.INDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06496724 | A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer | unknown | N/A | 1 | JIANG LONGWEIOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05754983 | Risk Factors and Long-term Impact of ICIs | unknown | — | 1,000 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06530511 | Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL | unknown | Phase 2 | 30 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06805071 | Decisional Regret in Open Partial Horizontal Laryngectomy | unknown | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05623956 | Proteomics in Small Cell Lung Cancer(SCLC-OMICS) | unknown | — | 50 | Aalborg University HospitalOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06527300 | A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer | unknown | Phase 2 | 48 | Zhejiang Wenda Pharma Technology LTD.INDUSTRY | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06562140 | Multidimensional Examination of Patients with Colorectal and Anal Cancer(MECACP) | unknown | — | 300 | University of PecsOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06773260 | Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC(ELASTO-HCC) | unknown | — | 150 | Azienda Ospedaliero Universitaria Policlinico ModenaOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06784401 | Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer | unknown | — | 20 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06353061 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | unknown | Phase 2 | 51 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06771947 | Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning Model | unknown | — | 1,500 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT01753414 | Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC(POSTILV) | unknown | Phase 2 | 44 | Radiation Therapy Oncology GroupNETWORK | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06454175 | A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years | unknown | Phase 1 | 72 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 6, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Sep 9, 2025source: clinicaltrials